Veloxis Pharmaceuticals A/S Stock CBOE EUROPE EQUITIES
Equities
0IVI
DK0060048148
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- DKK | - |
Sales 2017 | 30.17M 4.36M | Sales 2018 | 39.49M 5.7M | Capitalization | 3.75B 542M |
---|---|---|---|---|---|
Net income 2017 | -9M -1.3M | Net income 2018 | -5M -722K | EV / Sales 2017 | 49.4 x |
Net Debt 2017 | 18.05M 2.61M | Net Debt 2018 | 29.38M 4.24M | EV / Sales 2018 | 95.8 x |
P/E ratio 2017 |
-154
x | P/E ratio 2018 |
-708
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 10% |
Managers | Title | Age | Since |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 16-02-29 |
Chief Tech/Sci/R&D Officer | - | 17-09-12 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
1st Jan change | Capi. | |
---|---|---|
+13.10% | 9.23B | |
-13.75% | 5B | |
+41.51% | 4.46B | |
+4.51% | 3.95B | |
+21.10% | 2.44B | |
-15.23% | 2.54B | |
-25.12% | 2.36B | |
+19.51% | 2.18B | |
+5.11% | 1.67B |
- Stock Market
- Equities
- VELO Stock
- 0IVI Stock